Cognitive behaviour therapy (CBT) for anxiety and depression in adults with mild intellectual disabilities (ID)

Cognitive behaviour therapy (CBT) for anxiety and depression in adults with mild intellectual disabilities (ID): a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN38099525

Enrollment

Registered

2011-03-25

Start date

2010-03-01

Completion date

Unknown

Last updated

2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, anxiety Mental and Behavioural Disorders Depressive episode

Interventions

1. CBT plus treatment as usual: Participants will receive up to 16 one-to-one manualised cognitive behavioural therapy treatment sessions over a period of 16 weeks (4 months) in addition to the usual

Moss, 2002). Those identified as cases (greater than 10 for depression and greater than 7 for anxiety) will be eligible for the study. The range of scores indicating severity is between 11 - 32 for de

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults aged 16 years and over (either sex) who have mild intellectual disability (as determined on the service register) 2. A disorder with one of the following International Classification of Diseases, version 10 (ICD-10) codes: F32, F33, F34, F38, F40, F41 (anxiety, depression or mixed affective states) 3. Only participants with English as their main/spoken language

Exclusion criteria

Exclusion criteria: 1. Participants with co-morbid conditions of substance misuse, autism and those already receiving psychological treatment 2. Service users with moderate/severe intellectual disability

Design outcomes

Primary

Measure	Time frame
Participants will be assessed to measure the severity of their cognitive aspects of anxiety and/or depression using two subscales of the Beck Youth Inventories (BYI). These will be Beck Anxiety Inventory Youth (BAI-Y) and Beck Depression Inventory Youth (BDI-Y). Both sub-scales will be administered at baseline, end of treatment (i.e. four months) and at follow-up (i.e. six months).	—

Secondary

Measure	Time frame
1. Costs will be measured by administration of the Client Service Receipt Inventory, intellectual disability version (CSRI-ID version) at baseline and end of treatment (i.e. four months) 2. A quality of life questionnaire (Manchester Short Assessment of Quality of Life) that consists of 16-items. Each item is rated on a seven-point satisfaction scale, from 1 = 'Couldn't be worse' to 7 = 'Couldn?t be better'. It will be administered at baseline and at the end of treatment (i.e. four months). 3. Satisfaction with treatment will be measured by using a modified client satisfaction questionnaire which will elicit the client's perception of the mental health service/intervention at baseline and end of treatment (i.e. four months) 4. There will also be an open question with prompts about the experience and process of therapy to both service users and their carers to gain a better understanding of how the intervention was perceived and valued	—

Measure

Time frame

1. Costs will be measured by administration of the Client Service Receipt Inventory, intellectual disability version (CSRI-ID version) at baseline and end of treatment (i.e. four months) 2. A quality of life questionnaire (Manchester Short Assessment of Quality of Life) that consists of 16-items. Each item is rated on a seven-point satisfaction scale, from 1 = 'Couldn't be worse' to 7 = 'Couldn?t be better'. It will be administered at baseline and at the end of treatment (i.e. four months). 3. Satisfaction with treatment will be measured by using a modified client satisfaction questionnaire which will elicit the client's perception of the mental health service/intervention at baseline and end of treatment (i.e. four months) 4. There will also be an open question with prompts about the experience and process of therapy to both service users and their carers to gain a better understanding of how the intervention was perceived and valued

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 29, 2026